Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical total assets
Total assets on the balance sheet at the end of each period.
Aethlon Medical's total assets was $6.24M at Jun 30, 2026. For fiscal 2026 it was $6.33M, down 13.9% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $19.42M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $6.33M | -13.9% |
| FY2025 | Mar 31, 2025 | $7.36M | -10.8% |
| FY2024 | Mar 31, 2024 | $8.25M | -52.9% |
| FY2023 | Mar 31, 2023 | $17.51M | -9.8% |
| FY2022 | Mar 31, 2022 | $19.42M | +82.0% |
| FY2021 | Mar 31, 2021 | $10.67M | +2.7% |
| FY2020 | Mar 31, 2020 | $10.39M | +151.9% |
| FY2019 | Mar 31, 2019 | $4.12M | -43.9% |
| FY2018 | Mar 31, 2018 | $7.35M | +325.9% |
| FY2017 | Mar 31, 2017 | $1.73M | -31.7% |
| FY2016 | Mar 31, 2016 | $2.53M | +83.2% |
| FY2015 | Mar 31, 2015 | $1.38M | -18.6% |
| FY2014 | Mar 31, 2014 | $1.70M | +241.3% |
| FY2013 | Mar 31, 2013 | $496.69K | -40.8% |
| FY2012 | Mar 31, 2012 | $838.69K | +47.9% |
| FY2011 | Mar 31, 2011 | $567.22K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $6.24M | -15.3% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $6.33M | -2.9% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $8.06M | -8.9% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $5.31M | -53.5% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $7.36M | -10.8% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $6.53M | -37.5% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $8.85M | -31.0% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $11.42M | -27.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $8.25M | -52.9% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $10.44M | -49.6% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $12.83M | -44.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $15.80M | -7.8% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $17.51M | -9.8% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $20.72M | -5.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $23.05M | -3.5% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $17.13M | -33.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $19.42M | +82.0% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $21.92M | +73.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $23.87M | +58.6% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $25.87M | +57.5% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $10.67M | +2.7% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $12.67M | +170.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $15.06M | +1074.6% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $16.43M | +460.1% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $10.39M | +151.9% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $4.68M | -5.4% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $1.28M | -75.7% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $2.93M | -54.6% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $4.12M | -43.9% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $4.95M | -13.9% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $5.27M | +360.1% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $6.45M | +1167.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $7.35M | +325.9% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $5.75M | +628.3% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $1.15M | +20.5% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $509.15K | -65.2% |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $1.73M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $789.60K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $950.84K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | $1.46M | – |
See a number that looks wrong?